Day One Biopharmaceuticals, Inc.
← Back to DAWN Overview

Day One Biopharmaceuticals, Inc. (DAWN)

Solvency & Capital Structure

Total Debt

$2.8M

Net Debt

-$438.3M

Day One Biopharmaceuticals, Inc. currently has $2.8M in total debt. Net debt is -$438.3M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

DAWNQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2025-12-310.000.44-0.44Net Cash0.510.5%
2025-09-300.000.45-0.45Net Cash0.510.6%
2025-06-300.000.45-0.45Net Cash0.520.6%
2025-03-310.000.47-0.47Net Cash0.530.5%
2024-12-310.000.53-0.53Net Cash0.580.4%
2024-09-300.000.56-0.56Net Cash0.600.4%
2024-06-300.000.36-0.36Net Cash0.400.0%
2024-03-310.000.32-0.32Net Cash0.330.1%
2023-12-310.000.37-0.37Net Cash0.380.1%
2023-09-300.000.41-0.41Net Cash0.410.1%
2023-06-300.000.44-0.44Net Cash0.450.1%
2023-03-310.000.32-0.32Net Cash0.320.2%
2022-12-310.000.34-0.34Net Cash0.350.2%
2022-09-300.000.37-0.37Net Cash0.380.3%
2022-06-300.000.39-0.39Net Cash0.400.3%
2022-03-310.000.26-0.26Net Cash0.270.1%
2021-12-310.000.28-0.28Net Cash0.290.1%
2021-09-300.000.30-0.30Net Cash0.300.1%
2021-06-300.000.31-0.31Net Cash0.320.1%
2021-03-310.000.15-0.15Net Cash0.160.2%
2020-12-310.000.04-0.04Net Cash0.050.9%